Design, Synthesis, and Anticancer Evaluation of Fused 1,2-diazine Derivatives†
AbstractCancer is one of the most serious and merciless health problems of humankind, and the number of new cases is expected to increase in the next decades. Despite extensive cancer research in order to find more effective drugs and treatments, cancer chemotherapy is complex and complicated, because of the limited eﬃcacy of drugs, significant levels of toxicity, and lack of selectivity, and the emergence of drug resistance and multidrug resistance make the situation even worse. We report here the design, synthesis, structure, and in vitro anticancer activity of two series of compounds derived from pyridazine and phthalazine. The in vitro anticancer activity was tested on a panel of 60 human tumor cell lines representing cancers of the brain, breast, colon, kidney, lung, ovary, prostate, as well as leukemia and melanoma, to the National Cancer Institute (USA). The test was conducted on a single dose and five dose assay. Notably, from the tested compounds, five of them show very good anticancer activity (superior to Doxorubicin, the NCI standard drug for this type of analysis), with a growth inhibition in the area of nanomolar, between 20–100 nM, on several cancer cell lines: breast cancer MCF7, colon cancer HCT-15, KM12 and SW-620, leukemia K562 and SR, melanoma MDA-MB-435, SK-MEL-5, and UACC-62, and renal cancer A498. SAR correlation in the two series and in between the two series has been performed. One compound has an excellent anticancer activity against breast cancer MCF7 cell, leukemia SR cell, and melanoma MDA-MB-435 cell, in the area of 20 nM.
Share & Cite This Article
Vasilichia, A.; Dorina, A.-M.; Violeta, M.; Ramona, D.; Ionel, M.I. Design, Synthesis, and Anticancer Evaluation of Fused 1,2-diazine Derivatives. Proceedings 2019, 22, 26.
Vasilichia A, Dorina A-M, Violeta M, Ramona D, Ionel MI. Design, Synthesis, and Anticancer Evaluation of Fused 1,2-diazine Derivatives. Proceedings. 2019; 22(1):26.Chicago/Turabian Style
Vasilichia, Antoci; Dorina, Amariucai-Mantu; Violeta, Mangalagiu; Ramona, Danac; Ionel, Mangalagiu I. 2019. "Design, Synthesis, and Anticancer Evaluation of Fused 1,2-diazine Derivatives." Proceedings 22, no. 1: 26.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.